The following is a summary of the Owens & Minor, Inc. (OMI) Q2 2024 Earnings Call Transcript:

Financial Performance:

• Owens & Minor reported a Q2 revenue of $2.7 billion, up 4% compared to the prior year.

• Gross profit for the quarter was $544 million, reflecting a margin expansion of 11 basis points from the previous year.

• GAAP operating income for the quarter increased by 87% year-over-year to $20.3 million, and adjusted operating income was up 23% at $76.3 million.

Business Progress:

• Announced the acquisition of Rotech Healthcare Holdings, aligning with strategic plans to expand the Patient Direct business to a revenue target of $5 billion by 2028.

• Reported advancements in operational efficiencies, reducing manufacturing, transportation, and distribution costs with improvements in both major business segments making strides towards their strategic goals.

Opportunities:

• Demographic trends indicating a growth in chronic conditions provide a solid base for the expansion of the Patient Direct segment.

• The acquisition of Rotech Healthcare Holdings is expected to enhance service delivery and reach in home-based healthcare.

Risks:

• Faced challenges with net new customer onboarding, which extended backlogs into Q2, potentially impacting future service timelines and customer satisfaction.

More details: Owens & Minor IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.